Evidence supporting specific protocol structures remains limited, and individualized assessment is required before extrapolating research findings to clinical practice
Phentermine and topiramate for weight loss are combined in an extended-release medication called Qsymia, approved for chronic weight management in qualifying patients
At 48 weeks, participants on the 8 mg dose achieved a mean body weight reduction of 22.8%, while those on the highest 12 mg dose achieved a mean reduction of 24.2% compared to just 2.1% in the placebo group
Efficacy and safety of co-administered once-weekly cagrilintide 2 4 mg with once-weekly semaglutide 2 4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
Appetite and Ghrelin Pathway Effects Because GHS-R1a is the same receptor activated by endogenous ghrelin, the body's primary hunger-signaling hormone, GHRP-6 stimulates appetite through identical hypothalamic pathways